Compare KURA & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KURA | SDHC |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 176.7M |
| IPO Year | N/A | 2024 |
| Metric | KURA | SDHC |
|---|---|---|
| Price | $10.22 | $22.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 5 |
| Target Price | ★ $25.00 | $16.70 |
| AVG Volume (30 Days) | ★ 1.7M | 84.9K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $104,029,000.00 | ★ $998,173,000.00 |
| Revenue This Year | $138.16 | $0.47 |
| Revenue Next Year | $67.37 | $7.65 |
| P/E Ratio | ★ N/A | $101.09 |
| Revenue Growth | N/A | ★ 10.26 |
| 52 Week Low | $5.41 | $15.00 |
| 52 Week High | $12.49 | $33.18 |
| Indicator | KURA | SDHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.00 | 69.31 |
| Support Level | $10.80 | $19.72 |
| Resistance Level | $10.90 | $22.41 |
| Average True Range (ATR) | 0.60 | 1.12 |
| MACD | -0.22 | 0.24 |
| Stochastic Oscillator | 3.49 | 92.82 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.